Fischer A B, Mueller T, Roberts E F. "Method for the Synthesis of Levetiracetam impurity 8" [P]. US Patent, US 11326377 B2, 2020-01-26.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 左乙拉西坦杂质8 in Pharmaceutical Formulations". J. Chromatogr. A, 2020, 690, (1), 7921-7941.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 左乙拉西坦杂质8 as an Impurity". Talanta, 2015, 2103, (10), 6146-6151.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Levetiracetam impurity 8 Using HRMS and NMR". Chemosphere, 2020, 180, (10), 5187-5203.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 左乙拉西坦杂质8 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2011, 1583, (8), 2786-2804.